| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/19/2004 | WO2003044531A3 Functionalised support card and use thereof for the rapid diagnosis of an infarct based on an immunotest |
| 02/19/2004 | WO2003042364A3 Identifying and controlling the growth of estrogen-responsive cells |
| 02/19/2004 | WO2003040728A3 Method and apparatus for the determination of glucose |
| 02/19/2004 | WO2003038724A3 Methods and apparatus for protein sequence analysis |
| 02/19/2004 | WO2003036261A3 Drug development by rapid neuroimaging of neural cells |
| 02/19/2004 | WO2003034072A3 Diagnosis and therapy of conditions involving alms1 |
| 02/19/2004 | WO2003034028A3 Methods for identifying and using modulators of estrogen related receptor gamma |
| 02/19/2004 | WO2003033520A3 Anticancer vaccine and diganostic methods and reagents |
| 02/19/2004 | WO2003031970A3 Method and apparatus for diagnosing hemostasis |
| 02/19/2004 | WO2003025543A3 Methods of cytodiagnostic staging of neoplasia and squamous cell carcinoma |
| 02/19/2004 | WO2003023061A3 Reading, detection or quantification method, hybrids or complexes used in said method and the biochip using same |
| 02/19/2004 | WO2003018770A3 Amplified oncogenes and their involvement in cancer |
| 02/19/2004 | WO2003016904A3 Peptide sequence tags and method of using same |
| 02/19/2004 | WO2003016352A8 Monoclonal antibodies against fungi and methods for their use |
| 02/19/2004 | WO2003014731A3 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 02/19/2004 | WO2003008537A9 Epitope sequences |
| 02/19/2004 | WO2003004532A3 Q9ul33/q9nzz4 and q9h5p3 splice variants |
| 02/19/2004 | WO2002099085A3 Human secreted proteins |
| 02/19/2004 | WO2002088185A3 Pan-specific monoclonal antibody |
| 02/19/2004 | WO2002086101A3 Core-glycosylated hcv envelope proteins |
| 02/19/2004 | WO2002086100A3 Expression of core-glycosylated hcv envelope proteins in yeast |
| 02/19/2004 | WO2002083866A3 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 02/19/2004 | WO2002083852A3 Microfermentor device and cell based screening method |
| 02/19/2004 | WO2002082052A3 Blood Testing Device |
| 02/19/2004 | WO2002077613A3 Fluid property sensors |
| 02/19/2004 | WO2002077206A9 Compositiona and methods useful for hcv infection |
| 02/19/2004 | WO2002076380A3 Cytotoxic factors for modulating cell death |
| 02/19/2004 | WO2002074251A3 Monoclonal antibody therapy for pancreas cancer |
| 02/19/2004 | WO2002072863A8 Methods for large scale protein matching |
| 02/19/2004 | WO2002070732A3 Method for assaying non-spermine/spermidine activity of spermidine/spermine n1acetyltransferase (ssat) |
| 02/19/2004 | WO2002068386A3 Tools and methods for identifying ppar$g(d)-specific agonists and antagonists |
| 02/19/2004 | WO2002063298A3 Gap junction permeability assay |
| 02/19/2004 | WO2002063037A9 Method for identifying functional nucleic acids |
| 02/19/2004 | WO2002061417A3 Chemical or biological attack detection and mitigation system |
| 02/19/2004 | WO2002061086A3 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 02/19/2004 | WO2002057993A3 Method for evaluating conditional probabilities in biotechnology |
| 02/19/2004 | WO2002056004A3 Thin film electrophoresis apparatus and method |
| 02/19/2004 | WO2002052039A3 Methods for selecting and producing pharmaceutical compounds using a library responsive to transcription factors |
| 02/19/2004 | WO2002048389A3 Focussing of compound libraries using atomic electrotopological values |
| 02/19/2004 | WO2002048337A3 Secreted human proteins |
| 02/19/2004 | WO2002048184A8 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test |
| 02/19/2004 | WO2002046744A3 Method and device for machine diagnosis and especially, gear diagnosis |
| 02/19/2004 | WO2002046477A3 Endogenous retroviruses up-regulated in prostate cancer |
| 02/19/2004 | WO2002042328A3 Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon |
| 02/19/2004 | WO2002037113A3 Clinical and functional validation of targets from disseminated cancer cells |
| 02/19/2004 | WO2002028888A3 Mimotope of neisseria meningitides lipooligosaccharide and vaccines containing the same |
| 02/19/2004 | WO2001088190A3 Poly-primed amplification of nucleic acid sequences |
| 02/19/2004 | WO2001050127A8 Screening using biological target molecules with metal-ion binding sites |
| 02/19/2004 | US20040034882 Transgenic rodent with mutation in one allele of the corticotropin releasing factor receptor 2 protein for use as animal model in treating and diagnosing anxiety, depression, obesity and diabetes |
| 02/19/2004 | US20040034880 Comprises trangenic caenorhabditis elegans mutants associated with constitutive pharyngeal pumping, increased gut permeability and/or altered molecular transport for use as animal model and drug screening tools |
| 02/19/2004 | US20040034481 Computerized drug screening |
| 02/19/2004 | US20040034318 System for withdrawing blood |
| 02/19/2004 | US20040034292 Multivariate analysis of green to ultraviolet spectra of cell and tissue samples |
| 02/19/2004 | US20040034207 Crystal structure of antibiotics bound to the 30S ribosome and its use |
| 02/19/2004 | US20040034203 Polyol-modified silanes as precursors for silica |
| 02/19/2004 | US20040034097 Pesticidal activity of functionalized alkenes |
| 02/19/2004 | US20040034092 Such as 5,7,2-trihydroxy-6,8-dimethoxyflavone; plant extracts; side effect reduction; anxiolytic agents |
| 02/19/2004 | US20040033978 Antisense oligonucleotides complementary to and that hybridize with RNA, used for gene expression inhibition, prophylaxis and medical diagnosis |
| 02/19/2004 | US20040033975 Whole cell engineering using real-time metabolic flux analysis |
| 02/19/2004 | US20040033932 Myc targets |
| 02/19/2004 | US20040033627 Method and apparatus for detecting substances of interest |
| 02/19/2004 | US20040033626 Method for gold deposition |
| 02/19/2004 | US20040033625 Methods for high throughput and quantitative proteome analysis |
| 02/19/2004 | US20040033624 Membrane receptor reagent and assay |
| 02/19/2004 | US20040033623 Assay for detection of antigen in bodily fluid |
| 02/19/2004 | US20040033622 Methods of identifying heterogeneous features in an image of an array |
| 02/19/2004 | US20040033621 Identifying and detecting genetically engineered insecticidal proteins in corn powders using immunoaffinity chromatagraphy; immunoassay; insect resistant plants |
| 02/19/2004 | US20040033620 Device and method for collecting and measuring chemical samples pad surface in CMP |
| 02/19/2004 | US20040033614 Detection of oxidative intermediates in biological samples |
| 02/19/2004 | US20040033613 Using salvia protein expression patterns to diagnose disease and screen for presence and activity of drugs |
| 02/19/2004 | US20040033611 Apparatus in which a plurality of test devices, using optical sensors, can accurately and efficiently monitor and analyze bodily fluids in one operation |
| 02/19/2004 | US20040033592 Apparatus comprising cylindrical recesses for heating positioning and ejecting sample trays |
| 02/19/2004 | US20040033591 Automated protein analysis system |
| 02/19/2004 | US20040033586 Pasteurella and/or actinobacillus mutant coding polypeptide for prevention and treatment of infectious disease; veterinary medicine |
| 02/19/2004 | US20040033577 Herbicides test method |
| 02/19/2004 | US20040033576 Using crystalline cell surface protein for directed monomolecular bonding of molecular layers and/or their attachment to solid support; immobilized cells; micelles |
| 02/19/2004 | US20040033575 Monitoring concentration of released gases in cell and/or tissue system; evaluation of seed growth and effectiveness of insecticides; biological pest control |
| 02/19/2004 | US20040033565 Isolated human G-Protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 02/19/2004 | US20040033563 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 02/19/2004 | US20040033560 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033559 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033558 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033553 Determining concentration of coenzyme Q10 in blood plasma and/or serums using benzoquinone as oxidizing agent; for monitoring bioavailability of orally administered CoQ10 used as food supplement or as an adjunctive therapy |
| 02/19/2004 | US20040033551 Assay for low molecular weight heparin |
| 02/19/2004 | US20040033549 Quorum sensing signaling in bacteria |
| 02/19/2004 | US20040033546 Novel microarrays and methods of use thereof |
| 02/19/2004 | US20040033545 Quantitating pneumococcal surface protein in a vaccine composition containing aluminum hydroxide |
| 02/19/2004 | US20040033544 Polyclonal antibodies against fibrinogen degradation products and associated methods of production and use |
| 02/19/2004 | US20040033542 Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer |
| 02/19/2004 | US20040033541 Contacting a biological sample isolated from a patient with an agent that is specific for a MAGE-A4 HLA-B37 binding peptide, and determining the interaction between the agent and the MAGE-A4 HLA-B37 binding peptide as a determination of cancer |
| 02/19/2004 | US20040033540 Detecting helminth infection using synthetic larval proteins; immunoassay; parasiticides |
| 02/19/2004 | US20040033539 Developing drug treatment protocols using optical gradients for graft-vs-host disease patients suffering from oral lesions |
| 02/19/2004 | US20040033538 Administering to the animal an amount of a compound that binds a c-Myc protein effective to treat the disease caused by immunoglobulin E production and/or accumulation |
| 02/19/2004 | US20040033537 Method for differentiating irritable bowel syndrome from inflammatory bowel disease (IBD) and for monitoring persons with IBD using total endogenous lactoferrin as a marker |
| 02/19/2004 | US20040033536 Methods for identifying and using insecticides |
| 02/19/2004 | US20040033534 Using peptide mimetics to prevent binding and gene expression activation by phosphorylated aspartyl regulatory protein; decreasing development of antibiotic resistance in pathogenic bacteria; gene expression inhibition |
| 02/19/2004 | US20040033533 Method of diagnosing metabolic bone diseases |
| 02/19/2004 | US20040033532 Designing inhibitors of angiotensin-converting enzyme (ACE) for treating cardiovascular, hypertensive, kidney and atherosclerotic disorders |
| 02/19/2004 | US20040033531 Kit which utilizes fluorescent polarization to monitor nucleic acid hybridization |
| 02/19/2004 | US20040033530 High throughput purification, characterization and identification of recombinant proteins |